2017•Value in HealthOpen access

A Cost-Utility Analysis of Dutasteride Plus Tamsulosin Combination Therapy Versus Tamsulosin Monotherapy in The Treatment of Benign Prostatic Hyperplasia in Iran

Mohammad Peikanpour, Zahra Sharif, MJ Foroughi Moghadam

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tamsulosin, Medicine, Dutasteride, Urology, Combination therapy, 5 Alpha-Reductase Inhibitor, Population, Hyperplasia

Back to paper search Browse research topics Original source

A Cost-Utility Analysis of Dutasteride Plus Tamsulosin Combination Therapy Versus Tamsulosin Monotherapy in The Treatment of Benign Prostatic Hyperplasia in Iran — Research Paper | ScholarLens